MFI and frequency of NKG2D+ NK cells were decreased in T2DM patients, while activating receptor NKp46 expression was not affected (Figures 2B, D, and Supplementary Figure S2B). This evidence concerns the gene KLRK1 and type 2 diabetes mellitus.